Howard N. Hodis, M.D.
Menopause Keynote Lecture: Menopausal HRT and Reduction of CVD and All-Cause Mortality: It’s About Time and Timing | Wednesday, Oct. 19, 3:00 - 3:45 pm
We are excited to welcome Howard N. Hodis, M.D. as a lecture speaker at the ASRM 2021 Scientific Congress & Expo. He will be giving the Menopause Keynote Lecture: Menopausal HRT and Reduction of CVD and All-Cause Mortality: It’s About Time and Timing on Wednesday, October 20, 2021, from 3:00 pm to 3:45 pm.
There is an educational need to address with physicians and allied health professionals the misunderstandings and misperceptions surrounding the risks and benefits of hormone therapy in healthy menopausal women. Menopause as a risk factor for cardiovascular disease and all-cause mortality will be addressed. Reduction of cardiovascular disease and all-cause mortality when menopausal hormone therapy is initiated in younger women close to menopause will be examined and placed into clinical perspective with other primary preventive therapies.
With more than 26 years of continuous NIH funding, Dr. Hodis has extensive experience as Principal Investigator from 20 NIH projects including 8 randomized controlled trials integrating translational research, biomedical engineering, and integrative biology/medicine spanning basic, clinical, and genetic investigation. In addition, Dr. Hodis has an extensive collaborative record as Co-Principal Investigator or Co-Investigator on another 24 NIH projects. By leading a stable research team as director of the USC Atherosclerosis Research Unit, Dr. Hodis has successfully completed 10 single-center, randomized, double-blinded, placebo-controlled serial arterial imaging trials of menopausal hormone therapy, lipid-lowering therapy, insulin-sensitizers, nattokinase, vitamin E, vitamin B, and soy isoflavone supplementation.
In addition, as the director of the Atherosclerosis Research Unit Core Imaging and Reading Center (CIRC), Dr. Hodis has 25 years of experience in leading a stable team of highly trained and experienced imaging specialists in the coordination and conduction of over 25 predominantly NIH-funded human clinical studies that have included large national randomized controlled trials and epidemiological and community studies. The CIRC provides a variety of non-invasive arterial imaging services encompassing anatomical and physiological measurements of atherosclerosis developed by Dr. Hodis’ team providing a full array of research and experienced capability to support all investigational approaches that employ arterial imaging.